The estimated Net Worth of Emmanuel Blin is at least $1.15 Million dollars as of 10 March 2017. Emmanuel Blin owns over 13,275 units of Bristol-Myers Squibb Co stock worth over $1,151,049 and over the last 9 years Emmanuel sold BMY stock worth over $0.
Emmanuel has made over 5 trades of the Bristol-Myers Squibb Co stock since 2015, according to the Form 4 filled with the SEC. Most recently Emmanuel exercised 13,275 units of BMY stock worth $645,032 on 10 March 2017.
The largest trade Emmanuel's ever made was exercising 13,275 units of Bristol-Myers Squibb Co stock on 10 March 2017 worth over $645,032. On average, Emmanuel trades about 4,617 units every 103 days since 2015. As of 10 March 2017 Emmanuel still owns at least 23,689 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Emmanuel Blin stock trades at the bottom of the page.
Emmanuel's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, 345 PARK AVENUE, NEW YORK, NY, 10154.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: